These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

470 related items for PubMed ID: 12242171

  • 1. Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials.
    Deeks JJ, Smith LA, Bradley MD.
    BMJ; 2002 Sep 21; 325(7365):619. PubMed ID: 12242171
    [Abstract] [Full Text] [Related]

  • 2. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.
    Silverstein FE, Faich G, Goldstein JL, Simon LS, Pincus T, Whelton A, Makuch R, Eisen G, Agrawal NM, Stenson WF, Burr AM, Zhao WW, Kent JD, Lefkowith JB, Verburg KM, Geis GS.
    JAMA; 2000 Sep 13; 284(10):1247-55. PubMed ID: 10979111
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. What have we learned from the large outcomes trials of COX-2 selective inhibitors? The rheumatologist's perspective.
    Hochberg MC.
    Clin Exp Rheumatol; 2001 Sep 13; 19(6 Suppl 25):S15-22. PubMed ID: 11695246
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the incidence rates of selected gastrointestinal events reported for patients prescribed celecoxib and meloxicam in general practice in England using prescription-event monitoring (PEM) data.
    Layton D, Hughes K, Harris S, Shakir SA.
    Rheumatology (Oxford); 2003 Nov 13; 42(11):1332-41. PubMed ID: 12810929
    [Abstract] [Full Text] [Related]

  • 7. New directions in symptomatic therapy for patients with osteoarthritis and rheumatoid arthritis.
    Hochberg MC.
    Semin Arthritis Rheum; 2002 Dec 13; 32(3 Suppl 1):4-14. PubMed ID: 12528069
    [Abstract] [Full Text] [Related]

  • 8. Gastrointestinal safety of amtolmetin guacyl in comparison with celecoxib in patients with rheumatoid arthritis.
    Jajić Z, Malaise M, Nekam K, Koó E, Dankó K, Kovacs M, Scarpignato C.
    Clin Exp Rheumatol; 2005 Dec 13; 23(6):809-18. PubMed ID: 16396699
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of valdecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials.
    Edwards JE, McQuay HJ, Moore AR.
    Pain; 2004 Oct 13; 111(3):286-296. PubMed ID: 15363872
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The cost effectiveness of rofecoxib and celecoxib in patients with osteoarthritis or rheumatoid arthritis.
    Maetzel A, Krahn M, Naglie G.
    Arthritis Rheum; 2003 Jun 15; 49(3):283-92. PubMed ID: 12794781
    [Abstract] [Full Text] [Related]

  • 13. Celecoxib: a review of its use for symptomatic relief in the treatment of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis.
    McCormack PL.
    Drugs; 2011 Dec 24; 71(18):2457-89. PubMed ID: 22141388
    [Abstract] [Full Text] [Related]

  • 14. Celecoxib: a review of its use in osteoarthritis, rheumatoid arthritis and acute pain.
    Clemett D, Goa KL.
    Drugs; 2000 Apr 24; 59(4):957-80. PubMed ID: 10804043
    [Abstract] [Full Text] [Related]

  • 15. Renal safety and tolerability of celecoxib, a novel cyclooxygenase-2 inhibitor.
    Whelton A, Maurath CJ, Verburg KM, Geis GS.
    Am J Ther; 2000 May 24; 7(3):159-75. PubMed ID: 11317165
    [Abstract] [Full Text] [Related]

  • 16. Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial.
    Chan FK, Lanas A, Scheiman J, Berger MF, Nguyen H, Goldstein JL.
    Lancet; 2010 Jul 17; 376(9736):173-9. PubMed ID: 20638563
    [Abstract] [Full Text] [Related]

  • 17. Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis.
    Goldstein JL, Correa P, Zhao WW, Burr AM, Hubbard RC, Verburg KM, Geis GS.
    Am J Gastroenterol; 2001 Apr 17; 96(4):1019-27. PubMed ID: 11316141
    [Abstract] [Full Text] [Related]

  • 18. Upper gastrointestinal tolerability of celecoxib compared with diclofenac in the treatment of osteoarthritis and rheumatoid arthritis.
    McKenna F, Arguelles L, Burke T, Lefkowith J, Geis GS.
    Clin Exp Rheumatol; 2002 Apr 17; 20(1):35-43. PubMed ID: 11892706
    [Abstract] [Full Text] [Related]

  • 19. COX-2 selective inhibitors in the treatment of arthritis: a rheumatologist perspective.
    Hochberg MC.
    Curr Top Med Chem; 2005 Apr 17; 5(5):443-8. PubMed ID: 15974939
    [Abstract] [Full Text] [Related]

  • 20. Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison.
    Emery P, Zeidler H, Kvien TK, Guslandi M, Naudin R, Stead H, Verburg KM, Isakson PC, Hubbard RC, Geis GS.
    Lancet; 2005 Apr 17; 354(9196):2106-11. PubMed ID: 10609815
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.